• BranchLab, an AI platform focused on pharmaceutical commercialization workflows such as audience identification, activation, and measurement, raised a USD 26 million Series A led by McKesson Ventures, with participation from Sanofi Ventures.
• Round brought total funding to USD 35 million.
• Company said its platform is used by large drugmakers and has lifted marketing efficacy by about 70% across multiple therapeutic areas.
• Proceeds will fund expansion of enterprise deployments, deeper integrations across healthcare and media systems, and continued product buildout.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi Ventures published the original content used to generate this news brief on May 13, 2026, and is solely responsible for the information contained therein.